Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Hannah Robinson and Sarah Loving from the Department of Paediatrics were recognised in the annual awards hosted by the Thames Valley Clinical Research Network

Hannah Robinson (pictured above) won 'Outstanding contribution to Children’s Research (Memorial award)' for her work as a Senior Nurse / Clinical Co-ordinator with Oxford Vaccine Group (OVG) and Sarah Loving (pictured below) won 'Innovation in Patient and Public Involvement' for her work as Project Manager for the Vaccine Knowledge Project with OVG.

Sarah Loving AwardHealthcare professionals who help run research trials in the NHS were honoured at an awards ceremony at St Hilda’s College, Oxford on Tuesday, 26 September.

Doctors, nurses and researchers were among those recognised at the Thames Valley Health Research Awards.

They contribute to research supported by the NIHR Clinical Research Network Thames Valley and South Midlands (LCRN), a Department of Health-funded body that helps get trials under way in the NHS.

Read here for the full article on the NIHR Thames Valley CRN website.

Similar stories

Oxford to work with Brazil to establish clinical research hub

The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

Delayed second dose and third doses of the Oxford-AstraZeneca vaccine lead to heightened immune response

Research on the ChAdOx1 nCoV-19, also known as the Oxford-AstraZeneca vaccine, indicates that a long interval between first and second doses does not compromise the immune response after a late second dose.

COVID-19 vaccine messaging that focuses on personal benefits is most effective with those who are hesitant

For the one in ten who say they won’t take a COVID-19 vaccine, messaging that focuses on personal rather than collective benefits is more effective.

How do nucleic acid vaccines work?

Ever wondered what happens inside your cells when you are infected with a virus? Or wondered how the new COVID-19 vaccines work? The answer to both of these questions can be found in how our cells receive instructions to make proteins. Actually, our cells are a bit like factories...

Increasing vaccine uptake among ethnic minorities

Dr Samantha Vanderslott and Dr Seilesh Kadambari discuss their collaborative approach to providing ethnic minority groups with information on vaccines.